Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BL-7040 in Moderately Active Ulcerative Colitis
NCT01506362Phase 2Completed
- Sponsor
- BioLineRx Ltd.
- Start
- Mar 2012
- Primary completion
- May 2013
- Countries
- 1
01
Overview
A Phase 2 trial of BL-7040 in ulcerative colitis (UC), sponsored by BioLineRx Ltd.. Started Mar 2012; status: completed.
02
Drugs
BL-7040
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01506362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01506362.